期刊文献+

心脏手术术后发生急性肾损伤的相关因素 被引量:12

Influencing factors of postoperative acute kidney injury in patients undergoing cardiac surgery
原文传递
导出
摘要 目的分析使用左西孟旦或多巴酚丁胺的心脏手术术后患者发生急性肾损伤(AKI)的影响因素,并探究正性肌力药物对AKI的影响。方法回顾性研究。收集北京安贞医院2018年1至6月行心脏手术并在围手术期泵入左西孟旦或多巴酚丁胺患者的临床资料,并根据是否发生AKI将患者分为AKI组和非AKI组。采用单因素logistic回归分析AKI发生的相关因素,将单因素分析有统计学意义的因素(P<0.05)纳入多因素logistic回归分析模型。结果纳入研究的患者共417例,年龄(58.2±10.4)岁,男271例(65.0%),AKI发生率为25.2%(105/417)。单因素logistic回归分析结果显示,男性、慢性肾脏病、术前血肌酐水平高、主动脉阻断时间≥120 min,体外循环时间≥120 min均为心脏术后AKI的相关危险因素(均P<0.05);围手术期应用血管扩张剂、左西孟旦则为保护因素(均P<0.05)。多因素logistic回归分析结果显示,慢性肾脏病(OR=17.291,95%CI:4.335~68.960,P<0.001)、术前高血肌酐水平(OR=1.097,95%CI:1.074~1.121,P<0.001)为心脏术后AKI的独立危险因素,围手术期应用左西孟旦(OR=0.533,95%CI:0.288~0.984,P=0.044)为独立保护因素。结论心脏术后发生AKI的危险因素包括慢性肾脏病和术前高血肌酐水平,而围手术期左西孟旦的使用可能具有潜在的保护作用。 Objective To analyze the influencing factors of acute kidney injury(AKI)in patients after cardiac surgery using levosimendan or dobutamine,and explore the effect of positive inotropic drugs on AKI.Methods The clinical data of 417 patients undergoing cardiac surgery from January to June 2018 in Beijing Anzhen Hospital and treated with levosimendan or dobutamine during perioperative period were retrospectively reviewed and collected.Patients were divided into AKI group and non-AKI group according to whether AKI occurred.Univariate logistic regression analysis was used to analyze the factors related to the occurrence of AKI.The statistically significant factors(P<0.05)were further included in the multivariate logistic regression analysis.Results Totally,417 patients were enrolled in the study,with a mean age of(58.2±10.4)years old and a male rate of 65.0%(n=271),and the AKI incidence rate was 25.2%(105/417).Univariate logistic regression analysis showed that male,chronic kidney disease,high serum creatinine level in preoperative period,aortic obstruction time≥120 minutes and extracorporeal circulation time≥120 minutes were risk factors for AKI(all P<0.05).Vasodilator and levosimendan treatment during perioperative period were protective factors(P<0.05).Multivariate logistic regression analysis showed that chronic kidney disease(OR=17.291,95%CI:4.335-68.960,P<0.001)and high serum creatinine level(OR=1.097,95%CI:1.074-1.121,P<0.001)in preoperative period were independent risk factors for AKI.Perioperative application of levosimendan(OR=0.533,95%CI:0.288-0.984,P=0.044)was an independent protective factor.Conclusions Risk factors for AKI after cardiac surgery include chronic kidney disease and high serum creatinine level in preoperative period.The use of levosimendan during preoperative period has the potential effect to protect against AKI.
作者 张芸楠 贾明 潘昱 蔺建蕊 曹景琳 林阳 仇琪 Zhang Yunnan;Jia Ming;Pan Yu;Lin Jianrui;Cao Jinglin;Lin Yang;Qiu Qi(Department of Pharmacy,Beijing Artzhen Hospital,Capital Medical University,Beijing 100029,China;Cardiac Surgery Intensive Care Unit,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China;Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第12期928-932,共5页 National Medical Journal of China
基金 北京市医院管理局"扬帆计划"(ZYLX201805) 科技部十三五“新药创制”重大专项(2017ZX09304017)。
关键词 心脏外科手术 急性肾损伤 左西孟旦 Cardiac surgery Acute kidney injury Levosimendan
  • 相关文献

参考文献3

二级参考文献10

  • 1Andrew Shaw. Update on acute kidney injury after cardiac surgery [J]. J Thorac Cardiovasc Surg, 2012,143(3) :676.
  • 2Wolfgang Toiler, Lars Algotsson, Fabio Guavracino, et al. Perioperative use of levisomendan:best practice in operative settings [J].Joumal of Cardiothoracic and Vascular Anesthesia, 2013,27 (2) : 361.
  • 3Robert Harrison, Victor Hasselblad. Levosimendan reduces mortality in patients with reduced ejection fraction undergoing cardiac surgery:a Meta-analysis of randomized clinical TriMs [J]. JACC ,2012,59(13) : E959.
  • 4Ayse Baysal, Mehmet Yanartas, Mevlut Dogukan, et al.Levosimendan improves renal outcome in cardiac surgery : A randomized trial [ J]. Journal of Cardiothoracic and Vascular Anesthesia, 2014,28 (3) : 586.
  • 5Niu ZZ,Wu SM, Sun WY,et al. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery;a meta-analysis [J].J Cardiovasc Pharmacol,2014, 63 (2) : 107.
  • 6Englberger L, Suri RM, Li Z, et, al. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery [J]. Crit Care, 2011: 15: R16.
  • 7Robert AM, Kramer RS, Dacey LJ, et al. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria [J]. Ann Thorac Surg,2010,90: 1939.
  • 8Ishani A, Nelson D, Clothier B , et al. The magnitude of acute plasma creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease and death [J]. Arch Intern Med ,2011, 171 : 226.
  • 9Joachim Erb, Torsten Beutlhauser, Aarne Feldheiser, et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery [J]. Journal of International Medical Research, 2014,42 (3) : 750.
  • 10杜娟,郑哲.心脏手术相关性急性肾损伤的研究进展[J].心肺血管病杂志,2013,32(6):799-802. 被引量:7

共引文献7

同被引文献87

引证文献12

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部